Location History:
- Saint Foy les Lyon, FR (2022)
- Sainte Foy les Lyon, FR (2022 - 2024)
Company Filing History:
Years Active: 2022-2025
Title: Alban Mathieu: Innovator in Cancer Therapy
Introduction
Alban Mathieu is a prominent inventor based in Saint Foy les Lyon, France. He has made significant contributions to the field of cancer therapy through his innovative research and development of immunogenic compounds. With a total of 5 patents to his name, Mathieu is recognized for his dedication to advancing medical science.
Latest Patents
Among his latest patents, Mathieu has developed immunogenic compounds that comprise antigenic peptides with amino acid similarity to tumor antigens. These compounds are designed to enhance the immune response against cancer cells. The specific antigenic peptides are selected from a group that includes sequences described in the patent specifications, particularly those related to IL13RA2.
Career Highlights
Alban Mathieu has established a successful career in the biotechnology sector. He is currently associated with Enterome S.A., a company focused on developing innovative therapies for various diseases. His work has been instrumental in pushing the boundaries of cancer treatment and improving patient outcomes.
Collaborations
Mathieu collaborates with notable colleagues, including Laurent Chene and Matthieu Pichaud. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Alban Mathieu's contributions to cancer therapy through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical science and offers hope for improved cancer treatments.